Vivakor’s board of directors approved a stock dividend on common stock shares of HealthAmerica, a company that Vivakor owns more than 80% of their outstanding stock. This will allow shareholders to obtain one share of HealthAmerica for every share of Vivikor bought. December 1st is the assumed record date for the distribution with approval of FINRA. While December 9th is the date expected for distribution. Even after distribution Vivikor will continue to own over 60% of HealthAmericas outstanding common stock. Vivikor firmly stands behind HealthAmerica as a wonderful company and urges there shareholders to have confidence in their longterm strategy.
Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter
About Vivakor, Inc.
Vivakor(TM) is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds, that extend or improve life.
Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website
About Best Damn Penny Stocks
Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer
